These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11510787)

  • 1. Initial risk class and length of hospital stay in community-acquired pneumonia.
    Menéndez R; Ferrando D; Vallés JM; Martínez E; Perpiñá M
    Eur Respir J; 2001 Jul; 18(1):151-6. PubMed ID: 11510787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hospital admission, duration of stay and mortality in community-acquired pneumonia in an acute care hospital. Correlation between a pneumonia prognosis index and conventional clinical criteria for assessing severity].
    Calbo E; Ochoa de Echagüen A; Rodríguez-Carballeira M; Ferrer C; Garau J
    Enferm Infecc Microbiol Clin; 2004 Feb; 22(2):64-9. PubMed ID: 14756986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
    Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
    Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of the costs of care for community-acquired pneumonia.
    Bartolomé M; Almirall J; Morera J; Pera G; Ortún V; Bassa J; Bolíbar I; Balanzó X; Verdaguer A;
    Eur Respir J; 2004 Apr; 23(4):610-6. PubMed ID: 15083763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors associated with prolonged hospital stay in community-acquired pneumonia].
    Garcia-Vidal C; Carratalà J; Díaz V; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):160-4. PubMed ID: 19306716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of an instrument to assess the severity of community acquired pneumonia among hospitalized patients].
    Saldías F; Farías G; Villarroel L; Valdivia G; Mardónez JM; Díaz A
    Rev Med Chil; 2004 Sep; 132(9):1037-46. PubMed ID: 15543759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index.
    Riccioni G; Di Pietro V; Staniscia T; De Feudis L; Traisci G; Capani F; Ferrara G; Di Ilio E; Di Tano G; D'Orazio N
    Int J Immunopathol Pharmacol; 2005; 18(3):575-86. PubMed ID: 16164839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol Use Disorders and Community-Acquired Pneumococcal Pneumonia: Associated Mortality, Prolonged Hospital Stay and Increased Hospital Spending.
    Gili-Miner M; López-Méndez J; Béjar-Prado L; Ramírez-Ramírez G; Vilches-Arenas Á; Sala-Turrens J
    Arch Bronconeumol; 2015 Nov; 51(11):564-70. PubMed ID: 25766125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors impacting on length of stay and mortality of community-acquired pneumonia.
    Garau J; Baquero F; Pérez-Trallero E; Pérez JL; Martín-Sánchez AM; García-Rey C; Martín-Herrero JE; Dal-Ré R;
    Clin Microbiol Infect; 2008 Apr; 14(4):322-9. PubMed ID: 18190569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals.
    Jin Y; Marrie TJ; Carriere KC; Predy G; Houston C; Ness K; Johnson DH
    Epidemiol Infect; 2003 Feb; 130(1):41-51. PubMed ID: 12613744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital.
    Kaier K; Heister T; Götting T; Wolkewitz M; Mutters NT
    BMC Infect Dis; 2019 Dec; 19(1):1028. PubMed ID: 31795953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early mobilization of patients hospitalized with community-acquired pneumonia.
    Mundy LM; Leet TL; Darst K; Schnitzler MA; Dunagan WC
    Chest; 2003 Sep; 124(3):883-9. PubMed ID: 12970012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining length of hospital stay for pneumonia and postdischarge outcomes.
    Capelastegui A; España PP; Quintana JM; Gallarreta M; Gorordo I; Esteban C; Urrutia I; Bilbao A
    Am J Med; 2008 Oct; 121(10):845-52. PubMed ID: 18823851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy.
    Rhew DC; Hackner D; Henderson L; Ellrodt AG; Weingarten SR
    Chest; 1998 Jan; 113(1):142-6. PubMed ID: 9440581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.
    Fine MJ; Pratt HM; Obrosky DS; Lave JR; McIntosh LJ; Singer DE; Coley CM; Kapoor WN
    Am J Med; 2000 Oct; 109(5):378-85. PubMed ID: 11020394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia].
    Pişkin N; Aydemir H; Oztoprak N; Akduman D; Celebi G; Seremet Keskin A
    Mikrobiyol Bul; 2009 Oct; 43(4):597-606. PubMed ID: 20084912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?
    McCormick D; Fine MJ; Coley CM; Marrie TJ; Lave JR; Obrosky DS; Kapoor WN; Singer DE
    Am J Med; 1999 Jul; 107(1):5-12. PubMed ID: 10403346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
    Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
    BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.